The COVID-19 pandemic and its impact on the development of gestational diabetes mellitus (GDM) in West Virginia.
Appalachia
Coronavirus
Covid-19
Gestational Diabetes
West Virginia
Journal
Diabetes research and clinical practice
ISSN: 1872-8227
Titre abrégé: Diabetes Res Clin Pract
Pays: Ireland
ID NLM: 8508335
Informations de publication
Date de publication:
02 Feb 2024
02 Feb 2024
Historique:
received:
21
12
2023
revised:
22
01
2024
accepted:
29
01
2024
medline:
5
2
2024
pubmed:
5
2
2024
entrez:
4
2
2024
Statut:
aheadofprint
Résumé
To examine the rate of gestational diabetes mellitus (GDM) prevalence before and during the COVID-19 pandemic. Analysis revealed that GDM prevalence was significantly higher during the COVID-19 pandemic compared to pre-pandemic (8.59 % vs 7.77 %). The risk of GDM was 12 % higher during the pandemic vs. pre-pandemic (aRR = 1.12, 95 % CI 1.06, 1.19) and the aRD = 0.95 % (95 % CI 0.56 %, 1.33 %) adjusting for maternal age and substance use in pregnancy. GDM rates in WV increased from the period directly before the COVID-19 pandemic to during the COVID-19 pandemic. More research is needed to understand the pathophysiological mechanisms of pandemics and pandemic-related risk factors for this observed association. Supporting pregnant individuals during such events is critical to both maternal and child health.
Identifiants
pubmed: 38311246
pii: S0168-8227(24)00039-1
doi: 10.1016/j.diabres.2024.111126
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
111126Informations de copyright
Copyright © 2024 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.